Hypomagnesaemia in the first 10 days of severe leptospirosis

Annals of Tropical Medicine and Parasitology

Volumn 103, Issue 8, 2009, Pages 705-709

  Craig, S B ^a,b   Graham, G C ^a   Burns, M A ^a   Dohnt, M F ^a   Jansen, C C ^a   Smythe, L D ^a   McKay, D B ^b  

^a QUEENSLAND HEALTH   (Australia)

^b UNIVERSITY OF THE SUNSHINE COAST   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNESIUM;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; HUMAN; HYPOMAGNESEMIA; LEPTOSPIROSIS; MAGNESIUM DEFICIENCY; MENTAL HEALTH; MORBIDITY; MORTALITY; PROGNOSIS; TREATMENT OUTCOME;

ADULT; AGED; FEMALE; HUMANS; LEPTOSPIROSIS; MAGNESIUM; MAGNESIUM DEFICIENCY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 77949472030     PISSN: 00034983     EISSN: 13648594     Source Type: Journal    
DOI: 10.1179/000349809X12554106963717     Document Type: Article

References (17)

1. Anon. (2009). SYNCHRONH® Systems Magnesium Chemistry Information Sheet. Fullerton, CA: Beckman Coulter.
2. Craig, S. B., Graham, G. C., Burns, M.-A., Dohnt, M. F., Smythe, L. D. & McKay, D. B. (2009a). Haematological and clinical-chemistry markers in patients presenting with leptospirosis: a comparison of the findings from uncomplicated cases with those seen in the severe disease. Annals of Tropical Medicine and Parasitology, 103, 333-341.
3. Craig, S. B., Graham, G. C., Burns, M.-A., Dohnt, M. F., Smythe, L. D. & McKay, D. B. (2009b). Hypomagnesemia in acute leptospirosis. American Journal of Tropical Medicine and Hygiene, 80, 1067.
4. De Jorge, F. B. (1970). Concentrações de cobre, ceruloplasmina, magnésio e sulfato no sangue de pacientes com a forma hepato-rebak da diebça de Weil. Revista Brasileira de Medicina, 27, 449-451.
5. Esen, S., Sunbul, M., Leblebicioglu, H., Eroglu, C. & Turan, D. (2004). Impact of clinical and laboratory findings on prognosis in leptospirosis. Swiss Medical Weekly, 134, 347-352.
6. Faine, S. (1982). Guidelines for the Control of Leptospirosis, Geneva: World Health Organization.
7. Faine, S., Adler, B., Bolin, C. & Perolat, P. (1999). Leptospira and Leptospirosis, 2nd Edn. Melbourne, Australia: MediSci.
8. Khositseth, S., Sudjaritjan, N., Tananchai, P., Ongajyuth, S., Sitprija, V. & Thongboonkerd, V. (2008). Renal magnesium wasting and tubular dysfunction in leptospirosis. Nephrology, Dialysis, Transplantation, 23, 952-958.
9. Marotto, P. C. F., Nascimento, C. M. R., Eluf-Neto, J., Marotto, M. S., Andrade, L., Sztajnbok, J. & Seguro, A. C. (1999). Acute lung injury in leptospirosis: clinical and laboratory features, outcome, and factors associated with mortality. Clinical Infectious Diseases, 29, 1561-1563.
10. McClain, J. B., Ballou, W. R., Harrison, S. M. & Steinweg, D. L. (1984). Doxycyclin therapy for leptospirosis. Annals of Internal Medicine, 100, 696-698.
11. Panaphut, T., Domrongkitchaiporn, S., Vibhagool, A., Thinkamrop, B. & Susaengrat, W. (2003). Ceftriaxone compared with sodium penicillin G for the treatment of severe leptospirosis. Clinical Infectious Diseases, 36, 1508-1513.
12. Spichler, A., Athanazio, D. A., Furtado, J., Seguro, A. & Vinetz, J. M. (2008). Severe, symptomatic hypomagnesemia in acute leptospirosis. American Journal of Tropical Medicine and Hygiene, 79, 915-917.
13. Suputtamongkol, Y., Niwattayakul, K., Suttinont, C., Losuwanaluk, K., Limpaiboon, R., Chierakul, W., Wuthiekanun, V., Triengrim, S., Chenchittikul, M. & White, N. J. (2004). An open randomized, controlled trial of penicillin, doxycycline and cefotaxime for patients with severe leptospirosis. Clinical Infectious Diseases, 39, 1417-1424.
14. Swaminathan, R. (2003). Magnesium metabolism and its disorders. Clinical Biochemistry Reviews, 24, 47-66.
15. Watt, G., Padre, L. P., Tuazon, M. L., Calubaquib, C., Santiago, E., Ranoa, C. P. & Laughlin, L. W. (1988). Placebo-controlled trial of intravenous penicillin for severe late leptospirosis. Lancet, 8583, 433-435.
16. Whang, R. & Ryder, K. W. (1990). Frequency of hypomagnesemia and hypermagnesemia. Requested vs routine. Journal of the American Medical Association, 263, 3063-3064.
17. World Health Organization (2003). Human Leptospirosis: Guidance for Diagnosis, Surveillance and Control. Valletta: WHO.